Psychotic Disorders  >>  lisdexamfetamine  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lisdexamfetamine / Generic mfg.
NCT01263548: To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

Completed
N/A
45
Canada
lisdexamfetamine dimesylate, Vyvanse
University Health Network, Toronto, Shire
Attention Deficit/Hyperactivity Disorder, Bipolar Disorder
01/12
01/12

Download Options